Syncope (unknown origin) Signs and Symptoms Syncope and collapse
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult patients (greater than or equal to 18 years), agreeing to take part in the study and having signed the informed consent form 2. Patients having presented one or more episodes of syncope or pre-syncope unexplained by the usual screening tests: questionnaire, clinical examination, orthostatic hypotension investigation, biological tests, electrophysiological study (if necessary), echocardiogram (ECG), Holter, exercise test (optional), electroencephalogram (EEG) (optional), and brain scan (optional) 3. Negative sino-carotid massage (SCM) 4. Head-up tilt test conducted according to Appendix B protocol, whatever the result 5. Positive adenosine-5'-triphospate (ATP) test, confirmed by double reading by principal investigator
Exclusion criteria
Exclusion criteria: 1. Syncope etiology revealed by usual screening testings 2. Positive SCM 3. Atrial or ventricular tachyarrhythmia 4. Defibrillator implanted (DAI) 5. Pacemaker previously implanted 6. Patient on waiting list for or having had heart transplantation 7. Sick sinus syndrome, brady-tachy syndrome 8. Atrial fibrillation, paroxysmal or permanent first and second-degree atrio-ventricular block, trifascicular block 9. Ongoing pregnancy. Women of childbearing age should be using reliable contraception. 10. Acute systemic infection or other surgical contra-indication for pacemaker implantation 11. Chronic obstructive bronchopneumopathy 12. Asthma 13. Diabetes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence of syncope | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Duration of cardiac pause 2. Reprogramming of pacemaker 3. Recurrences after reprogramming | — |
Countries
Belgium, France